Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
Current Opinion in Investigational Drugs (London, England : 2000)|January 10, 2008
Evolution of schizophrenia drugs: a focus on dopaminergic systemsSham S Nikam, Alok K AwasthiCurrent Pharmaceutical Design|April 12, 2002
NR2B selective NMDA receptor antagonistsSham S Nikam, Leonard T MeltzerCurrent Opinion in Investigational Drugs (London, England : 2000)|January 10, 2008
Multi- and single-target agents for major psychiatric diseases: therapeutic opportunities and challengesErik H F Wong, Sham S Nikam, Mohammed ShahidBioorganic & Medicinal Chemistry Letters|December 28, 2007
1-Aminoindanes as novel motif with potential atypical antipsychotic propertiesJames M Graham, Linda L Coughenour, Bridget M Barr, et al.Bioorganic & Medicinal Chemistry Letters|February 26, 2004
Subtype selective NMDA receptor antagonists: evaluation of some novel alkynyl analoguesBrian E Kornberg, Sham S Nikam, Jon L Wright, et al.Journal of Medicinal Chemistry|June 23, 2006
3-arylimino-2-indolones are potent and selective galanin GAL3 receptor antagonistsMichael J Konkel, Bharat Lagu, Lakmal W Boteju, et al.Pageof 1